To better understand the in vivo mechanisms underlying this antitumor effect, we tested SNX3 expression in orthotropic KRASG13D mutant tumor sections by western blot analysis, and the results showed that SNX3 protein expression were strongly detected in saline group, whereas inhibited in honokiol combined with cetuximab or not (Figure S6B). The gene discussed is SNX3; the disease is neoplasm.